#hematology

• Abbasi clinical syndrome — Abbasi syndrome refers to a rare eponymic designation found in medical genetics and hematology reports, associated with the description of specific familial cases of congenital anemia or iron storage disorders documented in Middle Eastern clinical studies.
• ABO system — The major human blood group classification system (A, B, AB, and O), genetically determined by the presence or absence of specific antigens (agglutinogens) on the surface of red blood cells and antibodies (agglutinins) in the plasma. In modern medical lexicon, it functions as an invariable proper noun used to identify transfusion compatibility.
• Acanthocyte — A pathologically altered erythrocyte (red blood cell) characterized by an abnormal spherical or star-like shape, displaying multiple rigid, sharp cytoplasmic protrusions (spicules) of irregular length and distribution across its membrane. This morphological change (acanthocytosis) is caused by membrane lipid abnormalities and is encountered in severe conditions such as abetalipoproteinemia, advanced liver diseases, or neuroacanthocytosis.
• Acanthocytosis — A pathological condition characterized by the presence of an abnormally high number of acanthocytes (spurred erythrocytes with rigid, irregular membrane protrusions) in the peripheral blood. This morphological anomaly is closely linked to altered lipid metabolism and cell membrane structure, serving as a major diagnostic indicator for rare hereditary disorders (such as abetalipoproteinemia or McLeod syndrome), advanced end-stage liver diseases, or neurodegenerative disorders within the neuroacanthocytosis group.
• Achromatocyte — A pathologically degraded erythrocyte that has completely lost its hemoglobin content, appearing under the microscope as a pale, discolored, or empty cellular structure; a residual red blood cell (erythrocyte ghost) resulting from a severe hemolytic process or mechanical membrane trauma.
• Achromatocyte — A pathological erythrocyte cell form or degraded stage of a red blood cell that has partially or completely lost its normal hemoglobin content, appearing under the microscope as a pale, semitransparent, or fully pigment-depleted cellular structure. This structural phenomenon typically occurs following severe intravascular hemolysis, mechanical cell membrane trauma, or intense osmotic alterations, leaving behind a residual membrane known in specialized literature as an erythrocyte ghost.
• Adenogram — The written result, graphical representation, or quantitative and qualitative microscopic interpretation of the cells obtained by fine-needle aspiration of a lymph node or a gland. This structural laboratory investigation (also known as a lymphadenogram) establishes the percentage ratio between different cell types (lymphocytes, neutrophils, histiocytes) to differentiate an inflammatory reaction from a malignant proliferation.
• Aglobulia — A marked decrease or total absence of red blood cells (erythrocytes) in the blood, representing a severe and critical form of structural anemia. This hematological condition severely disrupts the blood's capacity to transport oxygen to biological tissues and is often caused by a severe dysfunction of the hematopoietic bone marrow.
• Agglutinin — A specific antibody or protein substance present in blood plasma or immune serum, capable of inducing the process of agglutination (clumping together) of foreign cells, bacteria, erythrocytes, or antigen-bearing particles. It plays a fundamental role in blood typing and in the immune defense mechanisms of the organism.
• Agglutino- — A learned combining form derived from scientific Latin, used as the first element in compound words within the medical, hematological, or biological fields. It carries the structural meaning of 'relating to agglutination', 'binding', or 'agglutinin', serving to form names of processes or biochemical compounds.
• Agglutinogen — An antigen substance, protein or carbohydrate in nature, located on the outer surface of the erythrocyte membrane, bacteria, or other biological cells. Its structural interaction with a specific agglutinin in the plasma triggers the agglutination reaction, serving as the core biochemical element that defines blood types within the ABO and Rh systems.
• Agglutinoscope — A laboratory optical device or instrument used for the examination, visual amplification, and precise determination of fine macroscopic or microscopic agglutination reactions. It facilitates the rapid reading of results in hemagglutination, immunology, or microbiology tests, allowing the observation of barely noticeable cell clumps.
• Agranulocyte — A type of leukocyte (white blood cell) characterized by the absence of specific granules in its cytoplasm and a non-lobed nucleus; agranulocytes include lymphocytes and monocytes, playing a vital role in adaptive immunity.
• Agranulocytic — Relating to agranulocytes or agranulocytosis; describing cellular phenomena, immune reactions, or clinical syndromes associated with white blood cells that lack specific cytoplasmic granules or with conditions marked by a severe depletion of granulocytes.
• Agranulocytosis — An acute and severe hematological condition characterized by a drastic reduction or near-complete disappearance of granulocytes (primarily neutrophils) in the peripheral blood, dropping below 500 per microliter. It leaves the body highly vulnerable to life-threatening infections.
• Aletocite — An extremely specialized scientific term or neologism used in experimental cell biology to describe a hypothetical or structurally modified blood cell, in an early stage of development or lacking specific granulations. In an extended academic sense, it can refer to a cytoplasmic component analyzed in controlled culture media.
• Aleukemia — A particular clinical form of leukemia characterized by the malignant proliferation of hematopoietic tissues, but in which the total number of leukocytes in the peripheral blood remains normal or even decreased, with tumor cells (blasts) being absent or extremely rare in the general circulation, although heavily present in the bone marrow.
• Aleukocytosis — A rare pathological condition characterized by the total absence or extreme, critical, and potentially fatal decrease of leukocytes (white blood cells) in the peripheral blood. It represents a severe manifestation of bone marrow aplasia or major hematopoietic disorders, exposing the organism to an imminent risk of massive opportunistic infections due to the complete collapse of the immune system.
• Allochromasia — An alteration or anomaly in the biological coloration of tissues, cells, or organic secretions, characterized by unusual, pathological, or varied hues compared to the normal state. In a strict clinical sense, the term can describe abnormal variations in staining affinity of blood cells during degenerative or infectious processes.
• Amphochromatophilic — Describing cells, tissues, or cellular structures: staining equally well with both acid and basic dyes; a structural biological property characterized by the ability to simultaneously absorb both types of histological pigments, resulting in a neutral or mixed hue following the staining fixation process.